B cell targeted CAR-T therapy for autoimmune diseases.

Chimeric antigen receptor T (CAR-T) cells demonstrate remarkable effectiveness in targeting and eliminating pathogenic B-cell lineages, showing significant specificity and efficacy against B cell malignancies. In addition, CAR-T cell-mediated B cell depletion and resetting, whic…

Criar conta gratuita para acessar o conteúdo completo